Greenleaf Peter 4/A
4/A · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4/AAmended
Greenleaf Peter
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2023-03-02$8.78/sh−33,047$290,153→ 982,671 total
Footnotes (1)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.